Endoscopy 2013; 45(02): 136-137
DOI: 10.1055/s-0032-1310123
Case report/series
© Georg Thieme Verlag KG Stuttgart · New York

Endoscopic submucosal dissection for duodenal tumors: a single-center experience

S. Matsumoto
Department of Gastroenterology, Saitama Medical Center, Jichi Medical University, Saitama, Japan
,
H. Miyatani
Department of Gastroenterology, Saitama Medical Center, Jichi Medical University, Saitama, Japan
,
Y. Yoshida
Department of Gastroenterology, Saitama Medical Center, Jichi Medical University, Saitama, Japan
› Author Affiliations
Further Information

Corresponding author

S. Matsumoto, MD
Department of Gastroenterology
Jichi Medical University
Saitama Medical Center
1-847 Amanuma, Omiya
Saitama 330-8503
Japan   
Fax: +81-48-6485188   

Publication History

submitted 31 January 2012

accepted after revision 02 May 2012

Publication Date:
28 August 2012 (online)

 

The indications for endoscopic submucosal dissection (ESD) for duodenal tumors have not yet been established. We reviewed our experience of ESD performed for duodenal tumors. We analyzed the data of a total of 13 patients with 14 duodenal lesions (excluding papillary lesions) comprising 2 early cancers, 5 adenomas, and 7 neuroendocrine tumors, who were treated by ESD between 2005 and 2011. The mean tumor diameter was 12.7 ± 14.8 mm. En bloc resection was achieved in 85.7 % of the cases. The procedure time was 89.1 ± 64.6 minutes. Intraoperative perforation occurred in three cases. The mean length of postoperative hospitalization was 8.4 ± 2.4 days. Because ESD for duodenal lesions was associated with a higher incidence of perforation than ESD for lesions in other locations (stomach, esophagus, and colon) reported previously, its use for duodenal lesions should be considered with caution.


#

Introduction

Although endoscopic submucosal dissection (ESD) has been widely accepted as a therapeutic procedure, the use of this technique for duodenal lesions remains controversial because of the technical difficulties and the high frequency of procedural complications [1]; nonetheless, there have been some reports of clinical experience of its use [2] [3] [4]. However, there have been no reports discussing the appropriate indications for ESD for duodenal tumors. Therefore, in this study we reviewed our experience of ESD performed for duodenal lesions (excluding papillary lesions), with the aim of helping to establish the indications for using ESD to treat duodenal lesions in the future.


#

Case report

The subjects of the study were 13 patients with 14 duodenal lesions (excluding papillary lesions) treated by ESD at the Saitama Medical Center between 2005 and 2011. The demographic characteristics of the patients, together with details of the procedures, are presented in [Table 1]. The 14 lesions included in this study were 2 early cancers, 5 adenomas, and 7 neuroendocrine tumors (NETs). The average age of the patients was 68 ± 5 years (range, 57 – 79 years), with a male:female ratio of 5:8. Of the 14 lesions, 8 were located in the duodenal bulb and the remaining 6 in the descending part of the duodenum. The mean tumor diameter was 12.7 ± 14.8 mm (range, 3 – 60 mm). The en bloc resection rate was 85.7 % (12 /14 cases). Piecemeal resection was performed in one case of a large elevated-type adenoma (no. 6), while in one case of a NET invading the deep layer of the submucosa (no. 12), ESD was discontinued and local excision was performed. The resection time was 89.1 ± 64.6 minutes. Perforation occurred in three cases. Emergency surgery was necessitated in two cases. Postprocedural bleeding occurred in one case. The mean length of postoperative hospitalization was 8.4 ± 2.4 days. No case of recurrence has been seen to date.

Table 1

Characteristics of 14 endoscopic submucosal dissections performed in 13 patients with duodenal tumors.

Case

Age, years

Sex

Location

Size, mm

Depth

Macroscopic type

Histology

Resection time, min

En bloc resection

Complications

Emergency surgery

Postoperative hospital stay, days

 1

66

F

D

 6

M

Depressed

Adenocarcinoma

 70

Yes

Perforation

No

12

 2

69

F

D

10

M

Depressed

Adenocarcinoma

217

Yes

No

 9

 3

74

F

D

 5

M

Depressed

Adenoma

 30

Yes

No

 6

 4

68

M

D

15

M

Elevated

Adenoma

 57

Yes

No

 8

 5

69

F

D

25

M

Elevated

Adenoma

 70

Yes

Postoperative bleeding

No

16

 6

64

M

B

60

M

Elevated

Adenoma

140

No

Intraoperative bleeding

No

 7

 7

68

M

D

15

M

Depressed

Adenoma

152

Yes

No

 8

 8

70

F

B

 3

SM

SMT

NET

 40

Yes

No

 7

 9

57

F

B

 4

SM

SMT

NET

 71

Yes

Perforation

Yes

 7

10

79

M

B

 6

M

SMT

NET

 81

Yes

No

 8

11

70

F

B

 5

SM

SMT

NET

 89

Yes

No

 8

12

74

M

B

 8

SM

SMT

NET

200

No

Intraoperative bleeding, perforation

Yes

11

13[1]

64

F

B

 7

SM

SMT

NET

 15

Yes

No

 5

14

64

F

B

 9

SM

SMT

NET

 15

Yes

No

 5

B, duodenal bulb; D, descending part of duodenum; M, mucosa; SM, submucosa; SMT, submucosal tumor; NET, neuroendocrine tumor.

1 Numbers 13 and 14 were the same patient.



#

Discussion

Endoscopic treatment of duodenal lesions is associated with a high incidence of complications, such as bleeding and perforation, because of the poor operability of lesions in this region using a scope, and because of the thinness of the duodenal wall. In particular, duodenal ESD is technically difficult, requires a longer procedure time, and is associated with a high risk of perforation [2] [3]. It is therefore important that the operator should be sufficiently skilled, with experience of having performed ESD safely and steadily at least for lesions in the stomach, esophagus, and large bowel.

When making the choice between endoscopic mucosal resection (EMR) and ESD in patients with duodenal tumors, the histopathology, macroscopic morphology, and size of the lesions should all be taken into account. EMR has been reported not only to be safe and useful for the treatment of duodenal adenomas, but also to yield a favorable long-term prognosis [5] [6]. Benign tumors such as hyperplastic polyps and adenomas can be safely resected piecemeal, and therefore EMR may be employed for such lesions. In comparison with en bloc resection, however, piecemeal resection is associated with a higher incidence of residual lesions and/or recurrence [6]. In addition, en bloc resection enables accurate pathological assessment of the deep and lateral margins of the resected lesions [7]. For this reason, en bloc resection is recommended for carcinomas and NETs; lesions amenable to en bloc resection by EMR may be resected by EMR, while those that are unlikely to be amenable to en bloc resection by EMR may be resected by ESD.

Among the complications associated with endoscopic treatment of duodenal lesions, bleeding is the most frequent and usually occurs within 24 hours after the procedure [5] [6] [8] [9]. Regarding perforation, caution is required to guard not only against intraprocedural perforation, but also against delayed perforation due to exposure to bile and pancreatic juice [2].

In conclusion, this study showed that ESD may be useful for some duodenal tumors. However, because duodenal ESD is associated with a relatively high incidence of complications, its use should be considered with caution. More clinical data need to be collected for clearer elucidation of the short-term and long-term outcomes of ESD for duodenal lesions.


#
#

Competing interests: None


Corresponding author

S. Matsumoto, MD
Department of Gastroenterology
Jichi Medical University
Saitama Medical Center
1-847 Amanuma, Omiya
Saitama 330-8503
Japan   
Fax: +81-48-6485188